With the introduction of the Fair Trade Compliance Program, it is needless to say that in order to continuously develop in society, a company should continuously comply with laws and regulations as the basics of management.
As all of you know, demand for fair competition in drug trade of pharmaceutical companies have been strengthened in recent years.
The pharmaceutical industry is attracting great expectations as a life-related industry that contributes to national health care and, furthermore, life and health around the world through the supply of pharmaceuticals, and as a high value-added industry that supports a mature economy.
In medical care, the purchase and selection of medicines must be determined by the appropriate judgment of the medical institution based on quality, price, and accurate information. In addition, providing gifts such as unfair money and services to medical institutions and medical personnel may distort the proper selection and use of medicines.
In particular, pharmaceuticals are products that are directly related to life, so end consumers are patients, not doctors who chooses the medicine, and public resources are used for this cost. Based on the above, the act of providing unfair gifts as a means of enticing purchases of medicines causes significant damage compared to other industries. In order to continuously secure the trust and credibility of society for all medicines, it is necessary to maintain and promote fair, transparent, and free competition in the supply of medicines without engaging in unfair promotional activities.From this point of view, Jinyang Pharm should not only establish a voluntary fair trade compliance program to prevent acts that violate the Fair Trade Act, but also strive to realize fair and transparent trade by thoroughly complying with it.
Thus, all executives and employees of Jinyang Pharm should act in accordance with the Fair Trade Compliance Program, and please be aware that individual penalties may be imposed if they fail to follow it.
Once again, we ask all executives and employees to make an effort to seek a better understanding from the industry as well as medical institutions and medical personnel regarding our efforts.
CEO and President